AbbVie EPS (Basic) increased by 920.0% to $1.02 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5200.0%, from $-0.02 to $1.02. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows a downward trend with a -22.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.42 | $1.78 | $2.27 | $2.52 | $0.52 | $2.22 | $1.39 | $0.13 | $1.14 | $1.00 | $0.46 | $0.77 | $0.77 | $0.88 | -$0.02 | $0.72 | $0.52 | $0.10 | $1.02 |
| QoQ Change | — | +323.8% | +27.5% | +11.0% | -79.4% | +326.9% | -37.4% | -90.6% | +776.9% | -12.3% | -54.0% | +67.4% | +0.0% | +14.3% | -102.3% | >999% | -27.8% | -80.8% | +920.0% |
| YoY Change | — | — | — | — | +23.8% | +24.7% | -38.8% | -94.8% | +119.2% | -55.0% | -66.9% | +492.3% | -32.5% | -12.0% | -104.3% | -6.5% | -32.5% | -88.6% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.